A groundbreaking gene therapy, BE-CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This ...

Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data ...

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

Four decades have passed since cochlear implants gave infants born deaf the ability to hear. Now, gene therapy promises to ...

Gene therapy is a revolutionary field in modern medicine, offering transformative potential to treat and potentially cure a wide range of genetic and acquired diseases. By addressing the root cause of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Topline results from a phase 3 clinical trial showed an ...

Gene therapy, a revolutionary approach to treating disease by modifying a person's genes, is one of the most transformative developments in healthcare today. In certain cases, it can offer a cure for ...

Vence L. Bonham Jr., Acting Deputy Director at the National Human Genome Research Institute (NHGRI) and an investigator in the National Human Genome Research Institute’s (NHGRI) Division of Intramural ...

About 100,000 people in the U.S. have sickle cell disease, a condition that primarily affects people of color, the CDC says.

Treatment with an intramuscular hepatocyte growth factor reduced healing time and promoted full ulcer healing compared with placebo in patients with peripheral artery disease.